BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25761483)

  • 1. Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1.
    Kim SY; Ko YS; Park J; Choi Y; Park JW; Kim Y; Pyo JS; Yoo YB; Lee JS; Lee BL
    Cancer Res Treat; 2016 Jan; 48(1):345-54. PubMed ID: 25761483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
    Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
    Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules.
    Kim SY; Yoon J; Ko YS; Chang MS; Park JW; Lee HE; Kim MA; Kim JH; Kim WH; Lee BL
    BMC Cancer; 2011 Jun; 11():264. PubMed ID: 21696576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.
    Ko YS; Cho SJ; Park J; Kim Y; Choi YJ; Pyo JS; Jang BG; Park JW; Kim WH; Lee BL
    Br J Cancer; 2015 Oct; 113(8):1186-96. PubMed ID: 26448177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.
    Stoeltzing O; McCarty MF; Wey JS; Fan F; Liu W; Belcheva A; Bucana CD; Semenza GL; Ellis LM
    J Natl Cancer Inst; 2004 Jun; 96(12):946-56. PubMed ID: 15199114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptide receptor a promotes gastric malignancy through angiogenesis process.
    Li Z; Fan H; Cao J; Sun G; Sen Wang ; Lv J; Xuan Z; Xia Y; Wang L; Zhang D; Xu H; Xu Z
    Cell Death Dis; 2021 Oct; 12(11):968. PubMed ID: 34671022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
    Prevete N; Liotti F; Visciano C; Marone G; Melillo RM; de Paulis A
    Oncogene; 2015 Jul; 34(29):3826-38. PubMed ID: 25263443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO1 reduces tumorsphere formation capacity and has crosstalk with LGR5 signaling in gastric cancer cells.
    Choi Y; Park J; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Lee BL
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1349-1355. PubMed ID: 28970066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigment epithelium-derived factor inhibits angiogenesis and growth of gastric carcinoma by down-regulation of VEGF.
    Zhang Y; Han J; Yang X; Shao C; Xu Z; Cheng R; Cai W; Ma J; Yang Z; Gao G
    Oncol Rep; 2011 Sep; 26(3):681-6. PubMed ID: 21617872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic inactivation of glycogen synthase kinase-3β promotes gastric tumor growth and angiogenesis by facilitating hypoxia-inducible factor-1 signaling.
    Ko YS; Cho SJ; Park J; Choi Y; Lee JS; Youn HD; Kim WH; Kim MA; Park JW; Lee BL
    APMIS; 2016 Sep; 124(9):748-56. PubMed ID: 27365055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
    J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling.
    Liu H; Liu N; Zhao Y; Zhu X; Wang C; Liu Q; Gao C; Zhao X; Li J
    Aging (Albany NY); 2019 Nov; 11(21):9643-9660. PubMed ID: 31689236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.
    Lim JH; Lee YM; Chun YS; Chen J; Kim JE; Park JW
    Mol Cell; 2010 Jun; 38(6):864-78. PubMed ID: 20620956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Akt phosphorylation on tumor growth and vascular endothelial growth factor expression in human gastric carcinoma.
    Kobayashi I; Semba S; Matsuda Y; Kuroda Y; Yokozaki H
    Pathobiology; 2006; 73(1):8-17. PubMed ID: 16785763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.
    Park J; Choi Y; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Park JW; Lee BL
    Cancer Res Treat; 2018 Jan; 50(1):239-254. PubMed ID: 28343375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin promotes angiogenesis by activating HIF-1α/β-catenin/VEGF signaling in gastric cancer.
    Tang E; Wang Y; Liu T; Yan B
    Gene; 2019 Jul; 704():42-48. PubMed ID: 30980943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
    Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
    PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.